Depending on your treatment history, TECENTRIQ can be taken alone or with other medicines

TECENTRIQ helped people with a type of metastatic non-small cell lung cancer (NSCLC) live longer

TECENTRIQ was studied in 2 clinical trials with over 1500 people with metastatic NSCLC.

TECENTRIQ + other medicines


Safety information you should be aware of

Possible serious side effects with TECENTRIQ include, but are not limited to, lung problems (pneumonitis), liver problems (hepatitis), intestinal problems (colitis), hormone gland problems (especially the thyroid, adrenal glands, pancreas, and pituitary), problems in other organs, severe infections and severe infusion reactions.

You can learn more about the signs and symptoms of these and other side effects in the TECENTRIQ Medication Guide.

Mary Ann is navigating the challenges of living with metastatic non-small cell lung cancer. Hear how she and her family are determined to face the challenges head on.

Learn about her experiences >

Receiving a different TECENTRIQ combination for NSCLC?

If you’re receiving nab-paclitaxel§ in addition to TECENTRIQ + carboplatin for your metastatic nsqNSCLC, learn about it here.

Considering whether TECENTRIQ is right for you?

Talking to Your Doctor About TECENTRIQ® (atezolizumab)

We can help you discuss treatment options with your doctor.